Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Celgene
says cancer drug Revlimid meets trial goal 3:32 PM 1/12/2010
Reuters
Celgene Corp's cancer drug Revlimid met the main goal of a late-stage trial of patients with multiple myeloma who had undergone a stem cell transplant.
...
US
FDA panel backs new use for Actelion drug 2:42 PM 1/12/2010
Reuters
A US advisory panel recommends approval of Actelion Ltd's Zavesca pill for patients with Niemann-Pick type C disease (NP-C). It's a rare disease that often kills patients in their teens after fats accumulate in their organs.
...
Pfizer
sees big Prevnar 13 sales among adults 12:09 PM 1/12/2010
Reuters
Pfizer Inc plans to seek approvals this year for use of its experimental Prevnar 13 vaccine among adults as the company awaits approval of the improved version of blockbuster Prevnar vaccine for infants and young children.
...
Tysabri
achieves blockbuster drug status 9:07 AM 1/12/2010
Boston Globe
Biogen Idec and Elan Corp's Tysabri achieved "blockbuster" status with more than $1 billion in 2009 sales. Patients on the therapy grew by 30 percent over 2008.
...
SciClone
says adjuvant raises H1N1 vaccine response 7:44 AM 1/12/2010
Reuters
SciClone Pharmaceuticals Inc's adjuvant Zadaxin in combination with Novartis' H1N1 vaccine increased immune response.
...
Vical
says PAD drug gets nod for late stage trial 6:56 AM 1/12/2010
Reuters
Vical Inc's Japanese partner AnGes MG Inc got a Special Protocol Assessment approval from US FDA for a late-stage clinical trial of its drug Collategene.
...
Proper
drug-taking would greatly cut heart risks 5:04 AM 1/12/2010
Reuters
British researchers suggest not widening the pool of patients as recommended by US government health advisers for some cholesterol-lowering statin drugs before encouraging those in high risk groups to take the statins they are prescribed.
...
New
Jersey Assembly Approves Medical Marijuana 4:44 AM 1/12/2010
New York Times
New Jersey will become the 14th state in the nation to legalize the use of marijuana to help patients with chronic illnesses.
...
US
panel rejects wider use of Forest drug 2:24 AM 1/12/2010
Reuters
A US advisory panel unanimously rejects Forest Laboratories Inc's bid to promote its hypertension pill Bystolic for treatment of heart failure.
...
Vical
Says Gov't Clears Melanoma Vaccine for Dogs 9:32 AM 1/11/2010
ABC News
Vical Inc said the US Agriculture Department approved its Oncept vaccine intended to treat oral melanoma in dogs. Oncept is licensed to the Merial Ltd division of Sanofi-Aventis.
...
Map
Pharma Rallies As No Added Study For Migrane Drug
Needed 9:13 AM 1/11/2010
Wall Street
Journal
The US FDA will not require MAP Pharmaceuticals Inc to run a new effectiveness study on its migraine drug candidate Levadex.
...
Idenix
Up On Positive Data From Hepatitus Drugs' Trials 9:03 AM 1/11/2010
Wall Street Journal
Idenix Pharmaceuticals reported progress in three of its hepatitis C drug development programs including its experimental hepatitis C (HCV) drug IDX184 which showed improvement in median ALT and AST levels.
...
Premier
research center testing Phase II drug 8:44 AM 1/11/2010
Bizjournals.com
Premier Research is testing new menstrual cramp drug VA111913 with UK-based Vantia Therapeutics. VA111913 may prevent the cause of cramps rather than treat symptoms.
...
Emergent
sees 2010 rev above Street view 7:55 AM 1/11/2010
Reuters
Emergent Biosolutions Inc expects to report 2010 revenue higher than market expectations driven partly by its anthrax vaccine BioThrax.
...
Vivus
Erectile-Dysfunction Drug Works Faster Than Rivals 7:33 AM 1/11/2010
Wall Street Journal
Vivus Inc said a late-stage trial of its erectile-dysfunction treatment avanafil had a surprisingly high magnitude of success in the first 15 minutes. Avanafil appeared to have fewer side effects than other treatments.
...
<- Day Earlier | Today's News
|
